News - Canada

Filter

Current filters:

Canada

Popular Filters

1 to 25 of 27 results

Chronic under-reporting of pharma R&D investment works against Canada

Chronic under-reporting of pharma R&D investment works against Canada

30-06-2014

A new KPMG study shows that R&D investments made by Canada's innovative pharmaceutical sector continue…

ApostropheCADCanadaEnglish spellingFinancialPharmaceuticalPharmaceutical sectorPoliticsPunctuationResearch

Debiopharm signs deal with Nobelex Biotech over antibiotics

Debiopharm signs deal with Nobelex Biotech over antibiotics

27-06-2014

Swiss pharma company Debiopharm Group and Canadian biotech company Nobelex Biotech have announced a collaboration…

Antibiotics and Infectious diseasesBiotechnologyCanadaDebiopharmLicensingNobelex Biotech

US FDA grants Valeant approval for Jublia NDA

US FDA grants Valeant approval for Jublia NDA

09-06-2014

Canadian drugmaker Valeant Pharmaceuticals International’s US subsidiary has received approval from…

CanadaDermatologicalsefinaconazoleJubliaPharmaceuticalRegulationUS Food and Drug AdministrationValeant Pharmaceuticals

Hospira refutes high pricing of paclitaxel during drug shortage

Hospira refutes high pricing of paclitaxel during drug shortage

08-06-2014

The Canadian subsidiary of USA-based injectable generic drugs specialist Hospira has refuted press reports…

CanadaGenericsHospiraMarkets & MarketingOncologyPaclitaxelPricing

Quebec first province to add Victoza to the drug benefit formulary

Quebec first province to add Victoza to the drug benefit formulary

04-06-2014

The Canadian subsidiary of Danish diabetes care giant Novo Nordisk says that the Quebec government has…

CanadaDiabetesFinancialHealthcareNovo NordiskPharmaceuticalVictoza

AbbVie files for Canadian approval of all-oral, interferon-free hepatitis C therapy

22-05-2014

US drugmaker AbbVie has filed a New Drug Submission to Health Canada seeking approval for its investigational,…

AbbVieAnti-viralsCanadaPharmaceuticalRegulation

USTR expresses growing concerns on IP protection in India and other markets

01-05-2014

The Office of the US Trade Representative (USTR) has released its annual “Special 301” Report on…

CanadaIndiaPatentsPharmaceuticalUSA

Canadian approval for GSK’s Incruse Ellipta as a treatment for COPD

17-04-2014

UK pharma giant GlaxoSmithKline says that Incruse Ellipta (umeclidinium) has received market authorization…

CanadaGlaxoSmithKlineIncruse ElliptaNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

US FDA approves NDA from Actavis and Valeant

US FDA approves NDA from Actavis and Valeant

26-03-2014

US generics major Actavis and Canada’s Valeant Pharmaceuticals said that the US Food and Drug Administration…

ActavisCanadaGenericsMetronidazolePharmaceuticalRegulationUSAValeant PharmaceuticalsWomen's Health

Health Canada approves Biogen Idec’s long-acting Alprolix hemophilia B

Health Canada approves Biogen Idec’s long-acting Alprolix hemophilia B

21-03-2014

US biotech firm Biogen Idec has announced that Health Canada has approved Alprolix for the control and…

AlprolixBiogen IdecCanadaHematologyPharmaceuticalRegulation

Generic drugs slow pharma spending growth in Canada

Generic drugs slow pharma spending growth in Canada

13-03-2014

Last year, C$29.3 billion ($26.47 billion) was spent on prescription drugs in Canada, but the annual…

CanadaFinancialGenericsMarkets & MarketingNorth AmericaPharmaceutical

Report: Global cystic fibrosis market value to treble by 2019

12-03-2014

The global cystic fibrosis market value in seven major countries will jump from $1.2 billion in 2013…

CanadaEuropeKalydecoMarkets & MarketingPharmaceuticalResearchRespiratory and PulmonaryUSAVertex

Servier Canada collaborates in two research projects

Servier Canada collaborates in two research projects

17-02-2014

Two major projects in clinical research conducted by Canada’s Montreal Heart Institute (MHI) and the…

CanadaCardio-vascularFinancialNorth AmericaPharmaceuticalResearchServier

Health Canada approves Celgene’s Pomalyst for multiple myeloma

Health Canada approves Celgene’s Pomalyst for multiple myeloma

12-02-2014

Regulatory agency Health Canada has approved US biotech firm Celgene’s drug Pomalyst (pomalidomide…

BiotechnologyCanadaCelgeneNorth AmericaOncologyPomalystRegulation

Domain Therapeutics opens North American subsidiary

20-01-2014

French biopharma company Domain Therapeutics, specializing in the R&D of new drug candidates targeting…

BiotechnologyCanadaDomain TherapeuticsManagementNorth America

iCo Therapeutics within reach of ‘holy grail’ cure in the $14 billion HIV market, says Edison

20-01-2014

Canadian biotech company iCo Therapeutics’s (iCO: TSX-V) compound AmpB could potentially allow the…

Anti-viralsBiotechnologyCanadaFinancialiCo TherapeuticsResearch

Ranbaxy cleared to market branded generic of Aricept in Canada

Ranbaxy cleared to market branded generic of Aricept in Canada

08-01-2014

The Canadian subsidiary of Ranbaxy Laboratories has received approval to manufacture and market RAN-Donepezil…

AriceptCanadaDaiichi SankyoEisaiGenericsNeurologicalNorth AmericaRAN-DonepezilRanbaxy LaboratoriesRegulation

Canadian Rx atlas maps billions in pharma savings – for now

Canadian Rx atlas maps billions in pharma savings – for now

02-01-2014

Canadians are spending less on prescription drugs for the first time since World War II, according to…

CanadaFinancialHealthcareNorth AmericaPharmaceutical

Gilead’s Sovaldi approved in Canada for Genotypes 1, 2, 3 or 4 HCV

Gilead’s Sovaldi approved in Canada for Genotypes 1, 2, 3 or 4 HCV

16-12-2013

US antiviral biotech specialist Gilead Sciences says that Health Canada has issued a Notice of Compliance…

Anti-viralsBiotechnologyCanadaGilead SciencesNorth AmericaRegulationsofosbuvirSovaldi

Alcon and ThromboGenics launch Jetrea in Canada

21-11-2013

ThromboGenics NV (Euronext Brussels: THR) and its partner Alcon, the ophthalmic unit of Novartis (NOVN:…

AlconBiotechnologyCanadaJetreaMarkets & MarketingOphthalmicsRegulationThromboGenics

1 to 25 of 27 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top